We are live on ! Find out more
TL

Tirschwell & Loewy Portfolio holdings

AUM $731M
1-Year Est. Return 15.44%
This Fund
S&P 500
This Quarter Est. Return
+7.36%
1 Year Est. Return
+15.44%
3 Year Est. Return
+77.99%
5 Year Est. Return
+97.61%
10 Year Est. Return
–
AUM
$567M
AUM Growth
+$36.3M
Cap. Flow
-$1.21M
Cap. Flow %
-0.21%
Top 10 Hldgs %
39.98%
Holding
84
New
4
Increased
23
Reduced
43
Closed
1

Top Buys

Rank Stock Value
1
ABMD
Abiomed Inc
ABMD
+$6.84M
2
CPHD
Cepheid Inc
CPHD
+$5.49M
3
INGN icon
Inogen
INGN
+$1.53M
4
WSM icon
Williams-Sonoma
WSM
+$942K
5
HPE icon
Hewlett Packard
HPE
+$467K

Top Sells

Rank Stock Value
1
SSYS icon
Stratasys
SSYS
+$4.64M
2
BIIB icon
Biogen
BIIB
+$2M
3
TRMB icon
Trimble
TRMB
+$1.84M
4
BF.B icon
Brown-Forman Class B
BF.B
+$936K
5
OXY icon
Occidental Petroleum
OXY
+$823K

Sector Composition

Rank Sector Weight
1 Healthcare 41.06%
2 Industrials 12.96%
3 Technology 10.32%
4 Consumer Staples 9.08%
5 Consumer Discretionary 8.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BIIB icon
1
Biogen
BIIB
$32.6B
$28.6M 5.04%
93,309
-6,977
-7% -$2M
TIF
2
DELISTED
Tiffany & Co.
TIF
$27M 4.76%
353,631
-1,905
-0.5% -$149K
BF.B icon
3
Brown-Forman Class B
BF.B
$12.3B
$24M 4.24%
756,953
-28,044
-4% -$936K
DHR icon
4
Danaher
DHR
$146B
$23.3M 4.11%
373,604
-7,067
-2% -$442K
NVO
5
Novo Nordisk
NVO
$206B
$23.1M 4.07%
794,460
-1,800
-0.2% -$49.8K
JNJ icon
6
Johnson & Johnson
JNJ
$663B
$22.6M 3.99%
220,306
-3,413
-2% -$343K
DXCM icon
7
DexCom
DXCM
$33.2B
$21.4M 3.76%
1,042,780
+11,000
+1% +$229K
NEOG icon
8
Neogen
NEOG
$2.58B
$20.5M 3.61%
965,883
-5,466
-0.6% -$111K
ADI icon
9
Analog Devices
ADI
$176B
$18.7M 3.3%
338,216
-5,365
-2% -$316K
RTN
10
DELISTED
Raytheon Company
RTN
$17.6M 3.1%
141,366
-3,250
-2% -$391K
CGNX icon
11
Cognex
CGNX
$10.5B
$17.3M 3.06%
1,026,840
-4,800
-0.5% -$85.6K
HON icon
12
Honeywell
HON
$66.4B
$17.3M 3.05%
186,059
-390
-0.2% -$35.8K
HSIC icon
13
Henry Schein
HSIC
$10B
$16.7M 2.94%
268,704
-5,061
-2% -$301K
GWW icon
14
W.W. Grainger
GWW
$62.4B
$14.7M 2.59%
72,595
-2,975
-4% -$611K
AMGN icon
15
Amgen
AMGN
$236B
$14.5M 2.55%
89,167
-600
-0.7% -$94.3K
SYT
16
DELISTED
Syngenta Ag
SYT
$14.4M 2.55%
183,519
-4,000
-2% -$286K
SLB icon
17
SLB Ltd
SLB
$85.3B
$13.8M 2.43%
197,882
-6,700
-3% -$502K
IDXX icon
18
Idexx Laboratories
IDXX
$42.2B
$13.3M 2.35%
183,055
-450
-0.2% -$32.1K
PODD icon
19
Insulet
PODD
$10.2B
$10.5M 1.85%
277,760
+615
+0.2% +$20.7K
CTXS
20
DELISTED
Citrix Systems Inc
CTXS
$10.4M 1.83%
172,639
-2,386
-1% -$147K
KMB icon
21
Kimberly-Clark
KMB
$34.9B
$10.2M 1.79%
79,827
-860
-1% -$103K
GE icon
22
GE Aerospace
GE
$350B
$9.85M 1.74%
65,988
-1,807
-3% -$257K
ROST icon
23
Ross Stores
ROST
$73.7B
$9.6M 1.69%
178,400
+3,900
+2% +$199K
WSM icon
24
Williams-Sonoma
WSM
$26.8B
$9.4M 1.66%
321,710
+27,520
+9% +$942K
ABBV icon
25
AbbVie
ABBV
$453B
$8.47M 1.49%
142,965
+1,650
+1% +$95K
1
2 3 4

Similar funds

IAS
INR Advisory Services Media, Pennsylvania $786M AUM 2.23% 1-Year Est. Return
ACM
Aviance Capital Management Sarasota, Florida $668M AUM 6.48% 1-Year Est. Return
MFBTD
MB Financial Bank - Trust Department Rosemont, Illinois $816M AUM 5.49% 1-Year Est. Return
SGAM
Steinberg Global Asset Management Boca Raton, Florida $639M AUM 11.04% 1-Year Est. Return
AB
AT Bancorp Dubuque, Iowa $823M AUM 0.35% 1-Year Est. Return
NTC
NF Trinity Capital Central, Hong Kong $626M AUM 3.16% 1-Year Est. Return
DCM
Daruma Capital Management New York $879M AUM 2.11% 1-Year Est. Return
DSI
Daiwa SB Investments Tokyo, Japan $506M AUM 11% 1-Year Est. Return

Tirschwell & Loewy's Q4 2015 Portfolio in Review

As of Q4 2015, Tirschwell & Loewy held 84 positions worth $567M, up 6.8% from $531M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Tirschwell & Loewy's Q4 2015 filing shows 4 new, 23 increased, 43 reduced and 1 closed positions. Its largest new stake was Abiomed Inc: 80,615 shares worth $7.28M. The largest sale was Stratasys, an estimated $4.64M.

By sector, the portfolio is most concentrated in Healthcare at 41% of assets, up from 38% a quarter earlier, followed by Industrials and Technology.

  • Tirschwell & Loewy's largest Q4 2015 buy was Abiomed Inc: 80,615 shares worth $7.28M.
  • Tirschwell & Loewy added most to Cepheid Inc in Q4 2015, an estimated $5.49M increase.
  • Tirschwell & Loewy's biggest Q4 2015 reduction was Stratasys, cutting an estimated $4.64M.
  • Tirschwell & Loewy fully exited Nektar Therapeutics in Q4 2015, selling an estimated $549K.
  • Tirschwell & Loewy's ten largest holdings make up 40% of its $567M portfolio in Q4 2015.
  • Tirschwell & Loewy opened 4 new positions and closed 1 in Q4 2015.
  • Tirschwell & Loewy's portfolio value rose 6.8% quarter-over-quarter to $567M.

Based on Tirschwell & Loewy's 13F filing for Q4 2015, filed 7 Jan 2016.